This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and DrugAdministration (FDA) Clearance for CardioSTAT® Press Release by: Icentia Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Food and DrugAdministration (FDA) Clearance for CardioSTAT® appeared first on Legacy MedSearch | Medical Device Recruiters.
Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.
Food and DrugAdministration (FDA) has approved the EMPAVELI Injector (enFuse ® ) for the subcutaneous delivery of EMPAVELI ® (pegcetacoplan), which is commercialized in the United States by Apellis Pharmaceuticals, Inc. “Enable’s purpose is to redefine drug delivery for the benefit of patients. .
Food and DrugAdministration (FDA). FOOD AND DRUGADMINISTRATION FOR STELLAR KNEE Press Release by: POLARISAR Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. See Full Press Release at the Source: POLARIS AR RECEIVES CLEARANCE FROM THE U.S.
Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceutical companies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months. Attending CPHI Barcelona 2023?
The world’s first AI-generated anti-fibrotic small molecule inhibitor drug has been administered to the first human patients. Phase II clinical trials in the US and China are now underway for INS018_055, Insilico Medicine’s potentially first-in-class oral drug candidate. Patients will be divided into four parallel cohorts.
Combined, DTx and DCTs improve patient recruitment, retention, and access, allowing researchers to pull from underserved communities, including rural populations. Orexo is a Swedish company that makes good money selling a drug called Zubsolv for opioid use disorder in the United States. The result was more diverse and inclusive data.
Food and DrugAdministration (FDA) 510(k) clearance for the company’s FreedomFlow Orbital Atherectomy Peripheral Platform. Food and DrugAdministration (FDA) 510(k) Clearance for its FreedomFlow® Orbital Atherectomy Peripheral Platform Press Release by: Cardio Flow, Inc. Cardio Flow, Inc. , Announces U.S.
EndoStim , a medical device company developing and commercializing a first-in-class implantable neurostimulation treatment for drug refractory gastroesophageal reflux disease (GERD), announced that the U.S. Food and DrugAdministration (FDA) granted Breakthrough Device Designation for the Company’s EndoStim System.
I have to laugh when I hear that a pharma company is patient-centric because that’s become a slogan to make employees feel good about themselves while the costs of prescription drugs increase every year. drug spending by 9 percent” What about taxpayers? Highest-paid CEOs in 2019: Who made the list from healthcare.
Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.
Merck’s old drugs are under more scrutiny, and anti-vaxxers are causing problems by cherry-picking unreliable information. I am reminded of a business colleague who left a company in the midwest after being recruited heavily by Amgen. prescriptions of finasteride, as the drug is known, for hair loss increased to over 2.4
Food & DrugAdministration (FDA) for its smaller-diameter CurvaFix® IM Implant indicated for fixation of fractures of the pelvis. Food & DrugAdministration (FDA). Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. CurvaFix, Inc.,
In June this year, it was announced that the US Food and DrugAdministration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses.
Food and DrugAdministration for its Respiratory Health point of care test. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Visby Medical announced that it has received Emergency Use Authorization (EUA) from the U.S. About Visby Medical.
Food and DrugAdministration (FDA) 510(k) clearance and launch of the company’s upgraded AI-powered software. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Hyperfine, Inc., The Swoop® system received initial U.S.
MicroPort Navibot has received 510(K) clearance from the Food and DrugAdministration (FDA) in the United States for the SkyWalker System, the company’s first robot-assisted platform for orthopedic applications. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry.
Food and DrugAdministration (FDA) 510(k) clearance for its CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with Fitzpatrick skin types I-III. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry.
Food and DrugAdministration (FDA) has cleared its Tasso+ lancet as a Class II medical device. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Tasso, Inc., the leading provider of convenient, clinical-grade blood collection solutions, announced that the U.S.
Food and DrugAdministration (FDA) 510(k) clearance for the Flex-Thread Ulna Intramedullary (IM) Nail System. Conventus Flower Orthopedics, an innovation-driven medical technology company, announced they have received U.S. Our clients include both blue-chip companies and innovative startups within the MedTech space.
Food and DrugAdministration (FDA) 510(k) clearance of the BiWaze ® Clear System. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. See Full Press Release at the Source: ABM RESPIRATORY CARE ANNOUNCES THE FDA CLEARANCE OF THE BIWAZE CLEAR SYSTEM.
Food and DrugAdministration (FDA) clearance for the company’s FreedomFlow® Peripheral Guidewire. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. appeared first on Legacy MedSearch | Medical Device Recruiters. Cardio Flow, Inc., The post Cardio Flow, Inc.,
Food and DrugAdministration (FDA) 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies. The post Lumendi Receives 510(k) Clearance for Two New Devices appeared first on Legacy MedSearch | Medical Device Recruiters.
Food and DrugAdministration has approved the company’s fourth-generation rechargeable sacral neuromodulation system. The post Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System appeared first on Legacy MedSearch | Medical Device Recruiters. Axonics, Inc.,
Food and DrugAdministration (FDA). Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. The post Promising Remote Patient Monitoring solution, Polso, Achieves 1st FDA Clearance appeared first on Legacy MedSearch | Medical Device Recruiters.
Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. The post IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit appeared first on Legacy MedSearch | Medical Device Recruiters. Press Release by: IRRAS.
Food and DrugAdministration (FDA) for 510(k) clearance. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. See Full Press Release at the Source: Inspira Technologies Begins Manufacturing of the ALICE CPB Device, ahead of planned 2023 FDA submission.
Food and DrugAdministration (FDA). Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. The post VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System appeared first on Legacy MedSearch | Medical Device Recruiters.
Food and DrugAdministration market clearance for the ArthroFree System. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. The company hit an important milestone in March 2022 when it received U.S. Press Release by: Lazurite.
Activ Surgical received 501(k)-clearance for ActivSight by the Food and DrugAdministration (FDA) in the United States in 2021. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. This is a proud day in Activ Surgical’s history.”. Press Release by: Activ Surgical.
Food and DrugAdministration (FDA) 510(k) clearance for its new NiTy+ One-Shot Staple Fixation System. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Press Release by: Tyber Medical. Contact us to discuss partnering with Legacy MedSearch on your position.
Food and DrugAdministration for commercial use in the United States. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. The post NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64 appeared first on Legacy MedSearch | Medical Device Recruiters.
Medinol today announced United States Food and DrugAdministration (FDA) approval for the EluNIR-PERL drug-eluting stent (DES) for the treatment of coronary artery disease. EluNIR-PERL builds upon the proven performance and clinical data of the EluNIR DES system. “We are pleased to bring technologies to the U.S.
Food and DrugAdministration (FDA) 510(k) clearance and launch of a next-generation RhinAer® stylus. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Aerin Medical Inc., Press Release by: Aerin Medical.
Food and DrugAdministration. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. The post Saranas Announces Over 1,200 Patients Treated with the Early Bird® Bleed Monitoring System appeared first on Legacy MedSearch | Medical Device Recruiters. Saranas, Inc.
Food and DrugAdministration (FDA) has granted an Investigational Device Exemption (IDE) to advance the company’s PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and effectiveness of the Vivasure PerQseal ® Closure Device System.
HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and DrugAdministration (FDA) for marketing in the USA or other geographies. The post HeartBeam Announces Acquisition of LIVMOR Assets appeared first on Legacy MedSearch | Medical Device Recruiters. For more information, visit HeartBeam.com.
Food and DrugAdministration (FDA) has granted the coveted Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Medcura, Inc., Press Release by: Medcura.
Food and DrugAdministration (FDA) for the Quantra Hemostasis System with QStat Cartridge. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Press Release by: HemoSonics, LLC. Contact us to discuss partnering with Legacy MedSearch on your position.
Food and DrugAdministration (FDA) 510(k) clearance of the LOBO-7 and LOBO-9 Vascular Occluders, the latest addition to the company’s LOBO ® Vascular Occlusion System. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Okami Medical Inc.,
Food and DrugAdministration (FDA). Food and DrugAdministration cleared the software for use in 2022. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Xironetic is headquartered in Oklahoma City. Press Release by: Xironetic.
While the Clarksville, US-based company completed a Phase Ia study in healthy participants to eventually develop the drug for Alzheimer’s disease, it is likely that the company will now focus on Parkinson’s disease in its Phase II study first, said Kelleher-Andersson. Similarly, research collaborations are also a consideration.
a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced Food and DrugAdministration (FDA) 510(k) clearance of their flagship intravascular imaging system, HyperVue. SpectraWAVE, Inc.,
Food and DrugAdministration (FDA) 510(k) clearance to aid in the early detection of sepsis for the approximately 30 million adult patients with signs and symptoms of infection who present to US emergency departments (ED) each year. For updates, follow Cytovale on LinkedIn and Twitter. Press Release by: Cytovale.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content